Transactions with shareholders
| For the years ended December 31, | ||||||||||||
|
(€‘000) |
2017 | 2016 | 2015 | |||||||||
|
Rent(1) |
— | 99 | 299 | |||||||||
|
Patent costs(2) |
— | — | 93 | |||||||||
|
Other |
— | — | — | |||||||||
|
|
|
|
|
|
|
|||||||
|
Total |
— | 99 | 392 | |||||||||
|
|
|
|
|
|
|
|||||||
| [1] | Relate to lease paid to Biological Manufacturing Services, company controlled by Tolefi SA until April 30, 2016 |
| [2] | Relate to Mayo License depreciation |
| [3] | Relate to directed research grant paid to Mayo Clinic under License Agreement |
| As of December 31, | ||||||||||||
|
(€‘000) |
2017 | 2016 | 2015 | |||||||||
|
Outstanding payables |
— | — | 39 | |||||||||
|
|
|
|
|
|
|
|||||||